UK Launches New mRNA Cancer Therapy Trial for Melanoma, Lung Cancer Treatment
The UK launches groundbreaking Mobilize trial using mRNA-4359 for melanoma and lung cancer, tapping into the patient's immune system for targeted and less toxic cancer treatment.